MarketCap
Facebook
X
TelegramAnnual report 2025
added 03-26-2026
Second Sight Medical Products ROE Ratio 2011-2026 | EYES
Annual ROE Ratio Second Sight Medical Products
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -169.16 | -133.37 | -123.56 | -31.35 | -518.17 | 2214.29 | -461.75 | -1137.94 | -361.79 | -297.62 | -98.79 | -101.68 | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 2214.29 | -1137.94 | -101.74 |
Quarterly ROE Ratio Second Sight Medical Products
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -731.52 | -265.62 | -142.6 | -76.47 | -102.35 | -95.27 | -92.94 | -62.49 | -59.72 | -31.07 | 74.29 | 438.97 | 386.92 | 140.53 | -136.02 | -673.41 | -429.25 | 52.91 | 705.56 | 2214.29 | 1914.02 | 1571.23 | 993.91 | -461.75 | -640.82 | -812.9 | -955.03 | -1137.94 | -944.71 | -753.59 | -582.27 | -361.79 | -360.81 | -351.75 | -341.21 | -297.62 | -231.62 | -174.51 | -115.74 | -24521.94 | -24534.15 | -24537.19 | -24541.46 | -101.68 | -62.46 | -40.38 | -18.6 | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 2214.29 | -24541.46 | -2155.06 |
ROE Ratio of other stocks in the Medical devices industry
| Issuer | ROE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
BIOLASE
BIOL
|
8353.04 | - | -13.19 % | $ 166 K |  USA |
 |
EDAP TMS S.A.
EDAP
|
-46.5 | $ 3.22 | - | $ 121 M |  France |
 |
GenMark Diagnostics, Inc.
GNMK
|
-19.79 | - | - | $ 1.77 B | USA |
 |
Globus Medical
GMED
|
11.76 | $ 93.7 | 0.07 % | $ 12.7 B | USA |
 |
AdaptHealth Corp.
AHCO
|
-4.66 | $ 13.08 | - | $ 1.77 B | USA |
 |
Allied Healthcare Products
AHPI
|
-36.97 | - | 3.58 % | $ 2.21 M | USA |
 |
BioSig Technologies
BSGM
|
-347.45 | - | 37.08 % | $ 85.7 M | USA |
 |
Avinger
AVGR
|
295.39 | - | -20.74 % | $ 369 K | USA |
 |
Lianluo Smart Limited
LLIT
|
-115.26 | - | 24.59 % | $ 44.8 M |  China |
 |
Axonics Modulation Technologies
AXNX
|
-10.47 | - | - | $ 3.31 B | USA |
 |
Aziyo Biologics
AZYO
|
192.9 | - | 1.37 % | $ 20.5 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
-264.39 | - | -5.86 % | $ 30.6 M | USA |
 |
Cardiovascular Systems
CSII
|
-14.8 | - | 0.15 % | $ 844 M | USA |
 |
LENSAR
LNSR
|
131.75 | $ 5.21 | 2.36 % | $ 62.3 M | USA |
 |
Pulmonx Corporation
LUNG
|
-99.79 | $ 1.28 | - | $ 52.1 M | USA |
 |
Conformis
CFMS
|
-93.16 | - | - | $ 16.4 M | USA |
 |
Orthofix Medical
OFIX
|
-20.49 | $ 12.32 | - | $ 488 M |  Curacao |
 |
Dynatronics Corporation
DYNT
|
-334.18 | - | 14.99 % | $ 929 K | USA |
 |
Cytosorbents Corporation
CTSO
|
-138.88 | $ 0.61 | - | $ 38 M | USA |
 |
Apollo Endosurgery
APEN
|
-122.23 | - | - | $ 475 M | USA |
 |
ClearPoint Neuro
CLPT
|
-91.15 | $ 11.21 | - | $ 317 M | USA |
 |
Sintx Technologies
SINT
|
-353.84 | $ 2.35 | - | $ 6.52 M | USA |
 |
Eargo
EAR
|
-156.15 | - | - | $ 10.2 M | USA |
 |
CryoLife, Inc.
CRY
|
-5.07 | - | -4.14 % | $ 702 M | USA |
 |
Electromed
ELMD
|
17.44 | $ 26.0 | - | $ 220 M | USA |
 |
Stryker Corporation
SYK
|
3.79 | $ 329.01 | -0.03 % | $ 126 B | USA |
 |
CHF Solutions, Inc.
CHFS
|
-910.25 | - | 1.15 % | $ 34.5 M | USA |
 |
Tactile Systems Technology
TCMD
|
8.72 | $ 24.24 | -3.31 % | $ 554 M | USA |
 |
TELA Bio
TELA
|
-615.1 | $ 0.8 | - | $ 37.6 M | USA |
 |
GBS
GBS
|
-352.75 | - | -0.57 % | $ 7.12 M | USA |
 |
TransMedics Group
TMDX
|
40.22 | $ 108.12 | - | $ 3.68 B | USA |
 |
Helius Medical Technologies
HSDT
|
-376.6 | $ 2.12 | - | $ 1.29 M | USA |
 |
Tandem Diabetes Care
TNDM
|
-0.38 | $ 19.82 | - | $ 1.35 B | USA |
 |
Soliton, Inc.
SOLY
|
-46.94 | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
-0.13 | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
-25.4 | - | 0.03 % | $ 1.58 B |  Israel |
 |
Misonix, Inc.
MSON
|
-11.88 | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
-1451.06 | - | - | $ 111 M |  Canada |
 |
Butterfly Network
BFLY
|
-42.94 | $ 5.48 | -0.09 % | $ 1.16 B | USA |
 |
Intersect ENT, Inc.
XENT
|
-107.92 | - | - | $ 955 M | USA |
 |
Varex Imaging Corporation
VREX
|
-14.88 | $ 12.71 | - | $ 526 M | USA |
 |
OrthoPediatrics Corp.
KIDS
|
-11.44 | $ 15.82 | - | $ 371 M | USA |
 |
Delcath Systems
DCTH
|
2.43 | $ 10.84 | - | $ 388 M | USA |
 |
Beyond Air
XAIR
|
-343.26 | $ 0.49 | - | $ 33.2 M | USA |
 |
LivaNova PLC
LIVN
|
-20.21 | $ 63.41 | - | $ 3.46 B |  Britain |
 |
IRIDEX Corporation
IRIX
|
-90.15 | $ 1.08 | - | $ 18.3 M | USA |
 |
Xtant Medical Holdings
XTNT
|
9.76 | $ 0.53 | - | $ 74 M | USA |
 |
Zimmer Biomet Holdings
ZBH
|
7.25 | $ 92.59 | - | $ 18.8 B | USA |
 |
CONMED Corporation
CNMD
|
4.55 | $ 37.87 | - | $ 1.18 B | USA |